Stryker Corporation Announces New Revolving Credit Agreement

Details

The new agreement provides for an aggregate principal amount of commitments of $3.0 billion, with a maturity date of February 25, 2030. The agreement also includes a leverage ratio financial covenant and an annual facility fee dependent on the company's credit ratings. A copy of the Credit Agreement is furnished as Exhibit 10.1.

Items reported

Exhibits (1)

About Stryker Corporation

Stryker Corporation is a prominent player in the medical technology industry, known for its innovative solutions across healthcare sectors such as orthopedics, medical and surgical, and neurotechnology and spine. The company's purpose is to enhance patient care through its wide array of products, including surgical equipment and advanced medical devices. Stryker plays a critical role in the healthcare market by providing essential tools and technologies that assist in improving surgical precision and patient recovery processes. With a continuous focus on research and development, Stryker Corporation remains at the forefront of medical advancements, directly impacting hospitals, surgical centers, and healthcare providers globally. The company's extensive distribution network and partnerships with medical professionals ensure that its technologies contribute to improving health outcomes across diverse geographical regions.